Biotech

All Articles

Novo inks $600M NanoVation package to examine genetic medicines ex-liver

.Novo Nordisk is continuing its push into genetic medications, consenting to pay NanoVation Therapie...

Innovent links cytokine to intestines cancer cells reactions

.Innovent Biologics has actually made the instance that its checkpoint inhibitor-cytokine blend prot...

Merck, Daiichi ADC reaches goal in phase 3 lung cancer cells research

.A stage 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina strengthens artificial intelligence center along with collab to choose cancer cells targets

.Five months after Rakovina Rehabs pivoted towards artificial intelligence, the cancer-focused biote...

Ascendis' dwarfism medication favorites in stage 3, endangers BioMarin

.Ascendis Pharma has actually emerged as a possible danger to BioMarin's Voxzogo, reporting period 3...

Despite ph. 3 miss, Alkeus sees road in advance for eye health condition asset

.Though Alkeus Pharmaceuticals' oral eye disease resource stopped working to substantially lower geo...

Kairos goes social with $6M IPO to finance tests of cancer medication

.Along with a triad of biotechs reaching the Nasdaq on Friday, it was actually quick and easy to ski...

Vaccine as well as Keytruda combo reliable in squamous cell cancer

.Immune system checkpoint preventions are the superheroes of cancer cells treatment. Medications lik...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and...

Regeneron's Opdualag rival presents 57% action rate

.Regeneron is back with long-lasting follow-up for its own LAG-3 inhibitor as well as PD-1 inhibitor...